Pharming seeks to register Rhucin in Turkey

Pharming Group NV said it will apply to market its human protein, Rhucin, in Turkey as part of a broader strategy to tap markets outside the European Union following the European Medicine Agency’s refusal to overturn a negative opinion on its marketing authorisation application for the product.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Netherlands